Global Oral Proton Pump Inhibitors (PPIs) Supply, Demand and Key Producers, 2024-2030

Page: 135

Published Date: 04 Jun 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Proton pump inhibitors (PPIs) are a group of medicines that decrease stomach acid production. They can help relieve symptoms of chronic acid reflux (GERD) and stomach ulcers. Proton pump inhibitors primarily treat conditions that arise when stomach acid irritates or damages parts of the digestive system, like stomach, duodenum (the part of your small intestine closest to the stomach) or food tube (esophagus).

The global Oral Proton Pump Inhibitors (PPIs) market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Oral Proton Pump Inhibitors (PPIs) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oral Proton Pump Inhibitors (PPIs) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Proton Pump Inhibitors (PPIs) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Oral Proton Pump Inhibitors (PPIs) total production and demand, 2019-2030, (K Units)
Global Oral Proton Pump Inhibitors (PPIs) total production value, 2019-2030, (USD Million)
Global Oral Proton Pump Inhibitors (PPIs) production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Oral Proton Pump Inhibitors (PPIs) consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Oral Proton Pump Inhibitors (PPIs) domestic production, consumption, key domestic manufacturers and share
Global Oral Proton Pump Inhibitors (PPIs) production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Oral Proton Pump Inhibitors (PPIs) production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Oral Proton Pump Inhibitors (PPIs) production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Oral Proton Pump Inhibitors (PPIs) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceutical, Pfizer, AstraZeneca, Eisai Co., Cipla Ltd., Aurobindo Pharma, Teva, Hetero Drugs, Nang Kuang Pharmacutical, Jean Marie Pharmacal, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Proton Pump Inhibitors (PPIs) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Oral Proton Pump Inhibitors (PPIs) Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Oral Proton Pump Inhibitors (PPIs) Market, Segmentation by Type:
    Rabeprazole
    Ilaprazole
    Esomeprazole
    Omeprazole
    Pantoprazole
    Others

Global Oral Proton Pump Inhibitors (PPIs) Market, Segmentation by Application:
    Hospital Pharmacy
    Retail Pharmacy

Companies Profiled:
    Takeda Pharmaceutical
    Pfizer
    AstraZeneca
    Eisai Co.
    Cipla Ltd.
    Aurobindo Pharma
    Teva
    Hetero Drugs
    Nang Kuang Pharmacutical
    Jean Marie Pharmacal
    Lizhu Group
    Luoxin Pharmaceutical
    Jiangsu Haosen Pharmaceutical Group
    Chengdu Dikang Pharmaceutical
    Jumpcan Pharmaceutical

Key Questions Answered:
1. How big is the global Oral Proton Pump Inhibitors (PPIs) market?
2. What is the demand of the global Oral Proton Pump Inhibitors (PPIs) market?
3. What is the year over year growth of the global Oral Proton Pump Inhibitors (PPIs) market?
4. What is the production and production value of the global Oral Proton Pump Inhibitors (PPIs) market?
5. Who are the key producers in the global Oral Proton Pump Inhibitors (PPIs) market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Oral Proton Pump Inhibitors (PPIs) Introduction
    1.2 World Oral Proton Pump Inhibitors (PPIs) Supply & Forecast
        1.2.1 World Oral Proton Pump Inhibitors (PPIs) Production Value (2019 & 2023 & 2030)
        1.2.2 World Oral Proton Pump Inhibitors (PPIs) Production (2019-2030)
        1.2.3 World Oral Proton Pump Inhibitors (PPIs) Pricing Trends (2019-2030)
    1.3 World Oral Proton Pump Inhibitors (PPIs) Production by Region (Based on Production Site)
        1.3.1 World Oral Proton Pump Inhibitors (PPIs) Production Value by Region (2019-2030)
        1.3.2 World Oral Proton Pump Inhibitors (PPIs) Production by Region (2019-2030)
        1.3.3 World Oral Proton Pump Inhibitors (PPIs) Average Price by Region (2019-2030)
        1.3.4 North America Oral Proton Pump Inhibitors (PPIs) Production (2019-2030)
        1.3.5 Europe Oral Proton Pump Inhibitors (PPIs) Production (2019-2030)
        1.3.6 China Oral Proton Pump Inhibitors (PPIs) Production (2019-2030)
        1.3.7 Japan Oral Proton Pump Inhibitors (PPIs) Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oral Proton Pump Inhibitors (PPIs) Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oral Proton Pump Inhibitors (PPIs) Major Market Trends

2 Demand Summary
    2.1 World Oral Proton Pump Inhibitors (PPIs) Demand (2019-2030)
    2.2 World Oral Proton Pump Inhibitors (PPIs) Consumption by Region
        2.2.1 World Oral Proton Pump Inhibitors (PPIs) Consumption by Region (2019-2024)
        2.2.2 World Oral Proton Pump Inhibitors (PPIs) Consumption Forecast by Region (2025-2030)
    2.3 United States Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030)
    2.4 China Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030)
    2.5 Europe Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030)
    2.6 Japan Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030)
    2.7 South Korea Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030)
    2.8 ASEAN Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030)
    2.9 India Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Oral Proton Pump Inhibitors (PPIs) Production Value by Manufacturer (2019-2024)
    3.2 World Oral Proton Pump Inhibitors (PPIs) Production by Manufacturer (2019-2024)
    3.3 World Oral Proton Pump Inhibitors (PPIs) Average Price by Manufacturer (2019-2024)
    3.4 Oral Proton Pump Inhibitors (PPIs) Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Oral Proton Pump Inhibitors (PPIs) Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Oral Proton Pump Inhibitors (PPIs) in 2023
        3.5.3 Global Concentration Ratios (CR8) for Oral Proton Pump Inhibitors (PPIs) in 2023
    3.6 Oral Proton Pump Inhibitors (PPIs) Market: Overall Company Footprint Analysis
        3.6.1 Oral Proton Pump Inhibitors (PPIs) Market: Region Footprint
        3.6.2 Oral Proton Pump Inhibitors (PPIs) Market: Company Product Type Footprint
        3.6.3 Oral Proton Pump Inhibitors (PPIs) Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Oral Proton Pump Inhibitors (PPIs) Production Value Comparison
        4.1.1 United States VS China: Oral Proton Pump Inhibitors (PPIs) Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Oral Proton Pump Inhibitors (PPIs) Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Oral Proton Pump Inhibitors (PPIs) Production Comparison
        4.2.1 United States VS China: Oral Proton Pump Inhibitors (PPIs) Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Oral Proton Pump Inhibitors (PPIs) Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Oral Proton Pump Inhibitors (PPIs) Consumption Comparison
        4.3.1 United States VS China: Oral Proton Pump Inhibitors (PPIs) Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Oral Proton Pump Inhibitors (PPIs) Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Oral Proton Pump Inhibitors (PPIs) Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Oral Proton Pump Inhibitors (PPIs) Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production (2019-2024)
    4.5 China Based Oral Proton Pump Inhibitors (PPIs) Manufacturers and Market Share
        4.5.1 China Based Oral Proton Pump Inhibitors (PPIs) Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Value (2019-2024)
        4.5.3 China Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production (2019-2024)
    4.6 Rest of World Based Oral Proton Pump Inhibitors (PPIs) Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Oral Proton Pump Inhibitors (PPIs) Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production (2019-2024)

5 Market Analysis by Type
    5.1 World Oral Proton Pump Inhibitors (PPIs) Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Rabeprazole
        5.2.2 Ilaprazole
        5.2.3 Esomeprazole
        5.2.4 Omeprazole
        5.2.5 Pantoprazole
        5.2.6 Others
    5.3 Market Segment by Type
        5.3.1 World Oral Proton Pump Inhibitors (PPIs) Production by Type (2019-2030)
        5.3.2 World Oral Proton Pump Inhibitors (PPIs) Production Value by Type (2019-2030)
        5.3.3 World Oral Proton Pump Inhibitors (PPIs) Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Oral Proton Pump Inhibitors (PPIs) Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacy
        6.2.2 Retail Pharmacy
    6.3 Market Segment by Application
        6.3.1 World Oral Proton Pump Inhibitors (PPIs) Production by Application (2019-2030)
        6.3.2 World Oral Proton Pump Inhibitors (PPIs) Production Value by Application (2019-2030)
        6.3.3 World Oral Proton Pump Inhibitors (PPIs) Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Takeda Pharmaceutical
        7.1.1 Takeda Pharmaceutical Details
        7.1.2 Takeda Pharmaceutical Major Business
        7.1.3 Takeda Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.1.4 Takeda Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Takeda Pharmaceutical Recent Developments/Updates
        7.1.6 Takeda Pharmaceutical Competitive Strengths & Weaknesses
    7.2 Pfizer
        7.2.1 Pfizer Details
        7.2.2 Pfizer Major Business
        7.2.3 Pfizer Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.2.4 Pfizer Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Pfizer Recent Developments/Updates
        7.2.6 Pfizer Competitive Strengths & Weaknesses
    7.3 AstraZeneca
        7.3.1 AstraZeneca Details
        7.3.2 AstraZeneca Major Business
        7.3.3 AstraZeneca Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.3.4 AstraZeneca Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 AstraZeneca Recent Developments/Updates
        7.3.6 AstraZeneca Competitive Strengths & Weaknesses
    7.4 Eisai Co.
        7.4.1 Eisai Co. Details
        7.4.2 Eisai Co. Major Business
        7.4.3 Eisai Co. Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.4.4 Eisai Co. Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Eisai Co. Recent Developments/Updates
        7.4.6 Eisai Co. Competitive Strengths & Weaknesses
    7.5 Cipla Ltd.
        7.5.1 Cipla Ltd. Details
        7.5.2 Cipla Ltd. Major Business
        7.5.3 Cipla Ltd. Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.5.4 Cipla Ltd. Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Cipla Ltd. Recent Developments/Updates
        7.5.6 Cipla Ltd. Competitive Strengths & Weaknesses
    7.6 Aurobindo Pharma
        7.6.1 Aurobindo Pharma Details
        7.6.2 Aurobindo Pharma Major Business
        7.6.3 Aurobindo Pharma Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.6.4 Aurobindo Pharma Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Aurobindo Pharma Recent Developments/Updates
        7.6.6 Aurobindo Pharma Competitive Strengths & Weaknesses
    7.7 Teva
        7.7.1 Teva Details
        7.7.2 Teva Major Business
        7.7.3 Teva Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.7.4 Teva Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Teva Recent Developments/Updates
        7.7.6 Teva Competitive Strengths & Weaknesses
    7.8 Hetero Drugs
        7.8.1 Hetero Drugs Details
        7.8.2 Hetero Drugs Major Business
        7.8.3 Hetero Drugs Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.8.4 Hetero Drugs Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Hetero Drugs Recent Developments/Updates
        7.8.6 Hetero Drugs Competitive Strengths & Weaknesses
    7.9 Nang Kuang Pharmacutical
        7.9.1 Nang Kuang Pharmacutical Details
        7.9.2 Nang Kuang Pharmacutical Major Business
        7.9.3 Nang Kuang Pharmacutical Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.9.4 Nang Kuang Pharmacutical Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Nang Kuang Pharmacutical Recent Developments/Updates
        7.9.6 Nang Kuang Pharmacutical Competitive Strengths & Weaknesses
    7.10 Jean Marie Pharmacal
        7.10.1 Jean Marie Pharmacal Details
        7.10.2 Jean Marie Pharmacal Major Business
        7.10.3 Jean Marie Pharmacal Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.10.4 Jean Marie Pharmacal Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Jean Marie Pharmacal Recent Developments/Updates
        7.10.6 Jean Marie Pharmacal Competitive Strengths & Weaknesses
    7.11 Lizhu Group
        7.11.1 Lizhu Group Details
        7.11.2 Lizhu Group Major Business
        7.11.3 Lizhu Group Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.11.4 Lizhu Group Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Lizhu Group Recent Developments/Updates
        7.11.6 Lizhu Group Competitive Strengths & Weaknesses
    7.12 Luoxin Pharmaceutical
        7.12.1 Luoxin Pharmaceutical Details
        7.12.2 Luoxin Pharmaceutical Major Business
        7.12.3 Luoxin Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.12.4 Luoxin Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Luoxin Pharmaceutical Recent Developments/Updates
        7.12.6 Luoxin Pharmaceutical Competitive Strengths & Weaknesses
    7.13 Jiangsu Haosen Pharmaceutical Group
        7.13.1 Jiangsu Haosen Pharmaceutical Group Details
        7.13.2 Jiangsu Haosen Pharmaceutical Group Major Business
        7.13.3 Jiangsu Haosen Pharmaceutical Group Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.13.4 Jiangsu Haosen Pharmaceutical Group Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Jiangsu Haosen Pharmaceutical Group Recent Developments/Updates
        7.13.6 Jiangsu Haosen Pharmaceutical Group Competitive Strengths & Weaknesses
    7.14 Chengdu Dikang Pharmaceutical
        7.14.1 Chengdu Dikang Pharmaceutical Details
        7.14.2 Chengdu Dikang Pharmaceutical Major Business
        7.14.3 Chengdu Dikang Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.14.4 Chengdu Dikang Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 Chengdu Dikang Pharmaceutical Recent Developments/Updates
        7.14.6 Chengdu Dikang Pharmaceutical Competitive Strengths & Weaknesses
    7.15 Jumpcan Pharmaceutical
        7.15.1 Jumpcan Pharmaceutical Details
        7.15.2 Jumpcan Pharmaceutical Major Business
        7.15.3 Jumpcan Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Product and Services
        7.15.4 Jumpcan Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.15.5 Jumpcan Pharmaceutical Recent Developments/Updates
        7.15.6 Jumpcan Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oral Proton Pump Inhibitors (PPIs) Industry Chain
    8.2 Oral Proton Pump Inhibitors (PPIs) Upstream Analysis
        8.2.1 Oral Proton Pump Inhibitors (PPIs) Core Raw Materials
        8.2.2 Main Manufacturers of Oral Proton Pump Inhibitors (PPIs) Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Oral Proton Pump Inhibitors (PPIs) Production Mode
    8.6 Oral Proton Pump Inhibitors (PPIs) Procurement Model
    8.7 Oral Proton Pump Inhibitors (PPIs) Industry Sales Model and Sales Channels
        8.7.1 Oral Proton Pump Inhibitors (PPIs) Sales Model
        8.7.2 Oral Proton Pump Inhibitors (PPIs) Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Oral Proton Pump Inhibitors (PPIs) Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Oral Proton Pump Inhibitors (PPIs) Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Oral Proton Pump Inhibitors (PPIs) Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Oral Proton Pump Inhibitors (PPIs) Production Value Market Share by Region (2019-2024)
 Table 5. World Oral Proton Pump Inhibitors (PPIs) Production Value Market Share by Region (2025-2030)
 Table 6. World Oral Proton Pump Inhibitors (PPIs) Production by Region (2019-2024) & (K Units)
 Table 7. World Oral Proton Pump Inhibitors (PPIs) Production by Region (2025-2030) & (K Units)
 Table 8. World Oral Proton Pump Inhibitors (PPIs) Production Market Share by Region (2019-2024)
 Table 9. World Oral Proton Pump Inhibitors (PPIs) Production Market Share by Region (2025-2030)
 Table 10. World Oral Proton Pump Inhibitors (PPIs) Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Oral Proton Pump Inhibitors (PPIs) Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Oral Proton Pump Inhibitors (PPIs) Major Market Trends
 Table 13. World Oral Proton Pump Inhibitors (PPIs) Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Oral Proton Pump Inhibitors (PPIs) Consumption by Region (2019-2024) & (K Units)
 Table 15. World Oral Proton Pump Inhibitors (PPIs) Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Oral Proton Pump Inhibitors (PPIs) Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Oral Proton Pump Inhibitors (PPIs) Producers in 2023
 Table 18. World Oral Proton Pump Inhibitors (PPIs) Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Oral Proton Pump Inhibitors (PPIs) Producers in 2023
 Table 20. World Oral Proton Pump Inhibitors (PPIs) Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Oral Proton Pump Inhibitors (PPIs) Company Evaluation Quadrant
 Table 22. World Oral Proton Pump Inhibitors (PPIs) Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Oral Proton Pump Inhibitors (PPIs) Production Site of Key Manufacturer
 Table 24. Oral Proton Pump Inhibitors (PPIs) Market: Company Product Type Footprint
 Table 25. Oral Proton Pump Inhibitors (PPIs) Market: Company Product Application Footprint
 Table 26. Oral Proton Pump Inhibitors (PPIs) Competitive Factors
 Table 27. Oral Proton Pump Inhibitors (PPIs) New Entrant and Capacity Expansion Plans
 Table 28. Oral Proton Pump Inhibitors (PPIs) Mergers & Acquisitions Activity
 Table 29. United States VS China Oral Proton Pump Inhibitors (PPIs) Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Oral Proton Pump Inhibitors (PPIs) Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Oral Proton Pump Inhibitors (PPIs) Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Oral Proton Pump Inhibitors (PPIs) Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Market Share (2019-2024)
 Table 37. China Based Oral Proton Pump Inhibitors (PPIs) Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Market Share (2019-2024)
 Table 42. Rest of World Based Oral Proton Pump Inhibitors (PPIs) Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Market Share (2019-2024)
 Table 47. World Oral Proton Pump Inhibitors (PPIs) Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Oral Proton Pump Inhibitors (PPIs) Production by Type (2019-2024) & (K Units)
 Table 49. World Oral Proton Pump Inhibitors (PPIs) Production by Type (2025-2030) & (K Units)
 Table 50. World Oral Proton Pump Inhibitors (PPIs) Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Oral Proton Pump Inhibitors (PPIs) Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Oral Proton Pump Inhibitors (PPIs) Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Oral Proton Pump Inhibitors (PPIs) Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Oral Proton Pump Inhibitors (PPIs) Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Oral Proton Pump Inhibitors (PPIs) Production by Application (2019-2024) & (K Units)
 Table 56. World Oral Proton Pump Inhibitors (PPIs) Production by Application (2025-2030) & (K Units)
 Table 57. World Oral Proton Pump Inhibitors (PPIs) Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Oral Proton Pump Inhibitors (PPIs) Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Oral Proton Pump Inhibitors (PPIs) Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Oral Proton Pump Inhibitors (PPIs) Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 62. Takeda Pharmaceutical Major Business
 Table 63. Takeda Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 64. Takeda Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Takeda Pharmaceutical Recent Developments/Updates
 Table 66. Takeda Pharmaceutical Competitive Strengths & Weaknesses
 Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
 Table 68. Pfizer Major Business
 Table 69. Pfizer Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 70. Pfizer Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Pfizer Recent Developments/Updates
 Table 72. Pfizer Competitive Strengths & Weaknesses
 Table 73. AstraZeneca Basic Information, Manufacturing Base and Competitors
 Table 74. AstraZeneca Major Business
 Table 75. AstraZeneca Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 76. AstraZeneca Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. AstraZeneca Recent Developments/Updates
 Table 78. AstraZeneca Competitive Strengths & Weaknesses
 Table 79. Eisai Co. Basic Information, Manufacturing Base and Competitors
 Table 80. Eisai Co. Major Business
 Table 81. Eisai Co. Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 82. Eisai Co. Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Eisai Co. Recent Developments/Updates
 Table 84. Eisai Co. Competitive Strengths & Weaknesses
 Table 85. Cipla Ltd. Basic Information, Manufacturing Base and Competitors
 Table 86. Cipla Ltd. Major Business
 Table 87. Cipla Ltd. Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 88. Cipla Ltd. Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Cipla Ltd. Recent Developments/Updates
 Table 90. Cipla Ltd. Competitive Strengths & Weaknesses
 Table 91. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
 Table 92. Aurobindo Pharma Major Business
 Table 93. Aurobindo Pharma Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 94. Aurobindo Pharma Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Aurobindo Pharma Recent Developments/Updates
 Table 96. Aurobindo Pharma Competitive Strengths & Weaknesses
 Table 97. Teva Basic Information, Manufacturing Base and Competitors
 Table 98. Teva Major Business
 Table 99. Teva Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 100. Teva Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Teva Recent Developments/Updates
 Table 102. Teva Competitive Strengths & Weaknesses
 Table 103. Hetero Drugs Basic Information, Manufacturing Base and Competitors
 Table 104. Hetero Drugs Major Business
 Table 105. Hetero Drugs Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 106. Hetero Drugs Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. Hetero Drugs Recent Developments/Updates
 Table 108. Hetero Drugs Competitive Strengths & Weaknesses
 Table 109. Nang Kuang Pharmacutical Basic Information, Manufacturing Base and Competitors
 Table 110. Nang Kuang Pharmacutical Major Business
 Table 111. Nang Kuang Pharmacutical Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 112. Nang Kuang Pharmacutical Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Nang Kuang Pharmacutical Recent Developments/Updates
 Table 114. Nang Kuang Pharmacutical Competitive Strengths & Weaknesses
 Table 115. Jean Marie Pharmacal Basic Information, Manufacturing Base and Competitors
 Table 116. Jean Marie Pharmacal Major Business
 Table 117. Jean Marie Pharmacal Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 118. Jean Marie Pharmacal Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. Jean Marie Pharmacal Recent Developments/Updates
 Table 120. Jean Marie Pharmacal Competitive Strengths & Weaknesses
 Table 121. Lizhu Group Basic Information, Manufacturing Base and Competitors
 Table 122. Lizhu Group Major Business
 Table 123. Lizhu Group Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 124. Lizhu Group Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. Lizhu Group Recent Developments/Updates
 Table 126. Lizhu Group Competitive Strengths & Weaknesses
 Table 127. Luoxin Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 128. Luoxin Pharmaceutical Major Business
 Table 129. Luoxin Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 130. Luoxin Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 131. Luoxin Pharmaceutical Recent Developments/Updates
 Table 132. Luoxin Pharmaceutical Competitive Strengths & Weaknesses
 Table 133. Jiangsu Haosen Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
 Table 134. Jiangsu Haosen Pharmaceutical Group Major Business
 Table 135. Jiangsu Haosen Pharmaceutical Group Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 136. Jiangsu Haosen Pharmaceutical Group Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 137. Jiangsu Haosen Pharmaceutical Group Recent Developments/Updates
 Table 138. Jiangsu Haosen Pharmaceutical Group Competitive Strengths & Weaknesses
 Table 139. Chengdu Dikang Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 140. Chengdu Dikang Pharmaceutical Major Business
 Table 141. Chengdu Dikang Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 142. Chengdu Dikang Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 143. Chengdu Dikang Pharmaceutical Recent Developments/Updates
 Table 144. Chengdu Dikang Pharmaceutical Competitive Strengths & Weaknesses
 Table 145. Jumpcan Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 146. Jumpcan Pharmaceutical Major Business
 Table 147. Jumpcan Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Product and Services
 Table 148. Jumpcan Pharmaceutical Oral Proton Pump Inhibitors (PPIs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 149. Jumpcan Pharmaceutical Recent Developments/Updates
 Table 150. Jumpcan Pharmaceutical Competitive Strengths & Weaknesses
 Table 151. Global Key Players of Oral Proton Pump Inhibitors (PPIs) Upstream (Raw Materials)
 Table 152. Global Oral Proton Pump Inhibitors (PPIs) Typical Customers
 Table 153. Oral Proton Pump Inhibitors (PPIs) Typical Distributors


List of Figures
 Figure 1. Oral Proton Pump Inhibitors (PPIs) Picture
 Figure 2. World Oral Proton Pump Inhibitors (PPIs) Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Oral Proton Pump Inhibitors (PPIs) Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Oral Proton Pump Inhibitors (PPIs) Production (2019-2030) & (K Units)
 Figure 5. World Oral Proton Pump Inhibitors (PPIs) Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Oral Proton Pump Inhibitors (PPIs) Production Value Market Share by Region (2019-2030)
 Figure 7. World Oral Proton Pump Inhibitors (PPIs) Production Market Share by Region (2019-2030)
 Figure 8. North America Oral Proton Pump Inhibitors (PPIs) Production (2019-2030) & (K Units)
 Figure 9. Europe Oral Proton Pump Inhibitors (PPIs) Production (2019-2030) & (K Units)
 Figure 10. China Oral Proton Pump Inhibitors (PPIs) Production (2019-2030) & (K Units)
 Figure 11. Japan Oral Proton Pump Inhibitors (PPIs) Production (2019-2030) & (K Units)
 Figure 12. Oral Proton Pump Inhibitors (PPIs) Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030) & (K Units)
 Figure 15. World Oral Proton Pump Inhibitors (PPIs) Consumption Market Share by Region (2019-2030)
 Figure 16. United States Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030) & (K Units)
 Figure 17. China Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030) & (K Units)
 Figure 18. Europe Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030) & (K Units)
 Figure 19. Japan Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030) & (K Units)
 Figure 22. India Oral Proton Pump Inhibitors (PPIs) Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Oral Proton Pump Inhibitors (PPIs) by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Oral Proton Pump Inhibitors (PPIs) Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Oral Proton Pump Inhibitors (PPIs) Markets in 2023
 Figure 26. United States VS China: Oral Proton Pump Inhibitors (PPIs) Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Oral Proton Pump Inhibitors (PPIs) Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Oral Proton Pump Inhibitors (PPIs) Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Market Share 2023
 Figure 30. China Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Oral Proton Pump Inhibitors (PPIs) Production Market Share 2023
 Figure 32. World Oral Proton Pump Inhibitors (PPIs) Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Oral Proton Pump Inhibitors (PPIs) Production Value Market Share by Type in 2023
 Figure 34. Rabeprazole
 Figure 35. Ilaprazole
 Figure 36. Esomeprazole
 Figure 37. Omeprazole
 Figure 38. Pantoprazole
 Figure 39. Others
 Figure 40. World Oral Proton Pump Inhibitors (PPIs) Production Market Share by Type (2019-2030)
 Figure 41. World Oral Proton Pump Inhibitors (PPIs) Production Value Market Share by Type (2019-2030)
 Figure 42. World Oral Proton Pump Inhibitors (PPIs) Average Price by Type (2019-2030) & (US$/Unit)
 Figure 43. World Oral Proton Pump Inhibitors (PPIs) Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 44. World Oral Proton Pump Inhibitors (PPIs) Production Value Market Share by Application in 2023
 Figure 45. Hospital Pharmacy
 Figure 46. Retail Pharmacy
 Figure 47. World Oral Proton Pump Inhibitors (PPIs) Production Market Share by Application (2019-2030)
 Figure 48. World Oral Proton Pump Inhibitors (PPIs) Production Value Market Share by Application (2019-2030)
 Figure 49. World Oral Proton Pump Inhibitors (PPIs) Average Price by Application (2019-2030) & (US$/Unit)
 Figure 50. Oral Proton Pump Inhibitors (PPIs) Industry Chain
 Figure 51. Oral Proton Pump Inhibitors (PPIs) Procurement Model
 Figure 52. Oral Proton Pump Inhibitors (PPIs) Sales Model
 Figure 53. Oral Proton Pump Inhibitors (PPIs) Sales Channels, Direct Sales, and Distribution
 Figure 54. Methodology
 Figure 55. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Takeda Pharmaceutical
Pfizer
AstraZeneca
Eisai Co.
Cipla Ltd.
Aurobindo Pharma
Teva
Hetero Drugs
Nang Kuang Pharmacutical
Jean Marie Pharmacal
Lizhu Group
Luoxin Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Chengdu Dikang Pharmaceutical
Jumpcan Pharmaceutical

Related Reports

Global Oral Proton Pump Inhibitors (PPIs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Oral Proton Pump Inhibitors (PPIs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 04 Jun 2024

date Pharma & Healthcare

Proton pump inhibitors (PPIs) are a group of medicines that decrease stomach acid production. They can help relieve symptoms of chronic acid reflux (GERD) and stomach ulcers. Proton pump inhibitors primarily treat conditions that arise when stomach acid irritates or damages parts of the digestive system, like stomach, duodenum (the part of your small intestine closest to the stomach) or food tube (esophagus).

Product Tags

Oral Proton Pump Inhibitors (PPIs)

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>